7-Aug-2026
Cantor Fitzgerald Sticks to Its Hold Rating for Healthpeak Properties (DOC)
TipRanks (Thu, 6-Aug 7:57 AM ET)
Healthpeak Properties Highlights Steady Progress in Earnings
TipRanks (Wed, 5-Aug 8:24 PM ET)
Analysts Offer Insights on Real Estate Companies: Macerich (MAC) and Healthpeak Properties (DOC)
TipRanks (Wed, 5-Aug 10:40 AM ET)
TipRanks (Wed, 5-Aug 9:30 AM ET)
Healthpeak Properties declares $0.1017 dividend
Seeking Alpha News (Wed, 5-Aug 9:05 AM ET)
TipRanks (Wed, 5-Aug 9:01 AM ET)
Healthpeak Q2 earnings beat as occupancy increases from prior quarter
Seeking Alpha News (Tue, 4-Aug 5:02 PM ET)
Healthpeak Properties Reports Strong Q2 Results, Capital Actions
TipRanks (Tue, 4-Aug 4:59 PM ET)
Healthpeak Properties FFO of $0.46 beats by $0.03, revenue of $771.58M beats by $46.42M
Seeking Alpha News (Tue, 4-Aug 4:18 PM ET)
Business Wire (Tue, 4-Aug 4:15 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of August 7, 2026, DOC stock price climbed to $21.41 with 3,799,210 million shares trading.
DOC has a beta of 0.31, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.02 to the broad based SPY ETF.
DOC has a market cap of $14.76 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $772 million in Revenue and $.46 earnings per share. This beat revenue expectation by $58 million and exceeded earnings estimates by $.02.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has outperformed the market in the last year with a return of +33.4%, while the SPY ETF gained +23.5%. In the last 3 month period, DOC beat the market returning +10.5%, while SPY returned +6.0%. However, in the most recent 2 weeks DOC has underperformed the stock market by returning -3.9%, while SPY returned +4.6%.
DOC support price is $20.75 and resistance is $21.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.